CONTINGENT PRODUCT RIGHTS

Miami Index Services Corporation

Application Filed: 2021-02-08
Trademark Application Details
Trademark Logo CONTINGENT PRODUCT RIGHTS

Mark For: CONTINGENT PRODUCT RIGHTS™ trademark registration is intended to cover the category of a non-equity dilutive form of financing whereby a person receives rights from a pharmaceutical or other such similar companies to a predesignated number of dosages of medicine or other medicinal products developed by pharmaceutical or other such similar companies if and when such products are approved by the Federal Drug Administration or such other governmental organization responsible for approving the medicinal product.

Status

2021-02-11 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number90517903
Mark Literal ElementsCONTINGENT PRODUCT RIGHTS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeService Mark
Current LocationNEW APPLICATION PROCESSING 2021-02-11
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
  • 102: Insurance and Financial
Primary International Class
  • 036 - Primary Class
  • (Insurance and financial) Insurance; financial affairs; monetary affairs; real estate affairs.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameSteven R. Goldberg

Timeline

2021-02-08Application Filed
2021-02-11Location: NEW APPLICATION PROCESSING
2021-02-11Status: Live/Pending
2021-02-11Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2021-02-11Transaction Date

Trademark Parties (Applicants & Owners)

Party: Miami Index Services Corporation
Address301 West 41st St., Suite 300 Miami Beach, FLORIDA UNITED STATES 33140
Legal Entity TypeCorporation
Legal Entity StateFLORIDA

Documents

ApplicationMULTI2021-02-08
DrawingJPEG2021-02-08

Attorney of Record

STEVEN R. GOLDBERG
STEVEN R. GOLDBERG, ESQ.
33 CHESTNUT ROAD
VERONA, NJ 07044

Good, Services, and Codes

International Codes:36
U.S. Codes:100,101,102
Type CodeType
GS0361A non-equity dilutive form of financing whereby a person receives rights from a pharmaceutical or other such similar companies to a predesignated number of dosages of medicine or other medicinal products developed by pharmaceutical or other such similar companies if and when such products are approved by the Federal Drug Administration or such other governmental organization responsible for approving the medicinal product
GS0361Financing services in the nature of a non-equity dilutive form of financing whereby an individual investor finances a pharmaceutical company for the company's development of medicine in exchange for rights from the pharmaceutical company to a predesignated number of dosages of the medicine developed from the utilization of the financing upon Federal Drug Administration approval of the medicine

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED IN TRAM2021-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed